Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

Market Cap	25.39B -9.6%
Revenue (ttm)	7.87B +32.2%
Net Income	1.38B
EPS	0.82
Shares Out	1.67B
PE Ratio	18.47
Forward PE	16.89
Dividend	0.80 (5.26%)
Ex-Dividend Date	Jun 16, 2026

Volume	9,323,877
Open	15.36
Previous Close	15.12
Day's Range	15.14 - 15.36
52-Week Range	14.22 - 21.58
Beta	0.41
Analysts	Strong Buy
Price Target	20.86 (+37.24%)
Earnings Date	Aug 29, 2026

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and personal protective equipment products; and TCM formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazh...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 11,343
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002603

Analyst Summary

According to 2 analysts, the average rating for 002603 stock is "Strong Buy." The 12-month stock price target is ¥20.86, which is an increase of 37.24% from the latest price.

Price Target

¥20.86

(37.24% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error